Hikma Pharmaceuticals USA Inc. recalls
Hikma Pharmaceuticals USA Inc. is named on 6 recalls in Recall Relay's records since November 2023, from FDA; the most recent was October 6, 2026.
All 6, newest first.
-
Class IIofficial
Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USPFailed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
-
Class IIofficial
Hikma Pharmaceuticals USA INC. recalls Ramipril Capsules USPFailed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
-
Class IIofficial
Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral SolutionThis recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
-
Class IIofficial
Hikma Pharmaceuticals USA Inc. recalls Lorazepam InjectionFailed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
-
Class Iofficial
Hikma Pharmaceuticals USA Inc. recalls Acetaminophen InjectionLabeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL)
-
Class IIofficial
Hikma Pharmaceuticals USA Inc. recalls Infumorph (Preservative-free Morphine Sulfate Sterile Solution)The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Hikma Pharmaceuticals USA Inc. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts